Investors

Sanderling Venture Partners
Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. Sanderling's investment philosophy is that significant companies are best built in close working partnerships with entrepreneurs. Sanderling emphasizes early-stage financing and active management of its portfolio companies. Sanderling and its principals play an active role in new ventures by providing seed and early-stage funding, contributing management leadership and administrative support, developing cost-control strategies to extend available dollars, supplying technical and regulatory expertise where needed, and offering the insight and perspective of those who have "done it before."

Archangel BioVentures, LLC
Archangel BioVentures was founded in 2001 and specializes in entrepreneurial biomedical investments. Archangel fills the gap between typical angel and venture capital investment amounts, and Archangel leverages its investment dollars by providing active management and advisory services to portfolio companies. Archangel typically invests in biomedical companies with existing products, proprietary technology, issued patents and existing or near-term revenue opportunities where a modest amount of capital can quickly accelerate the business.